All posts by: Michael Zand

Daily briefing: Xi’s power, Google’s Lyft bet and gene therapy – Financial Times

First-of-Its-Kind Gene Therapy Could Treat Blindness – Healthline

HealthlineFirst-of-Its-Kind Gene Therapy Could Treat BlindnessHealthlineA new treatment that could restore vision to people with a rare form of blindness may soon become the first-of-its-kind gene therapy to be approved by the U.S. Food and Drug Admini… Continue reading

For Key Study, UniQure Allowed to Swap Hemophilia Gene Therapies – Xconomy

XconomyFor Key Study, UniQure Allowed to Swap Hemophilia Gene TherapiesXconomyUniQure is trying to get to the finish line for a hemophilia B gene therapy by switching horses mid-race—and it says it has the blessing from regulators to make the unusual c… Continue reading

A revolutionary treatment could help more than 10000 people living with largely untreatable cancer – Business Insider UK

Business Insider UKA revolutionary treatment could help more than 10000 people living with largely untreatable cancerBusiness Insider UKThe highly personalized cancer treatment is a type of CAR T-cell therapy (CAR is short for chimeric antigen receptor… Continue reading

Fibrocell Science: A Very Appealing Gene Therapy Play – Seeking Alpha

Seeking AlphaFibrocell Science: A Very Appealing Gene Therapy PlaySeeking AlphaShares may have risen by over 50% year to date, but they are still in the red by almost 70% over the past three years. Interim results from a phase 1/2 clinical trial of dru… Continue reading

A revolutionary treatment could help more than 10000 people living with largely untreatable cancer – Markets Insider

Markets InsiderA revolutionary treatment could help more than 10000 people living with largely untreatable cancerMarkets InsiderThe highly personalized cancer treatment is a type of CAR T-cell therapy (CAR is short for chimeric antigen receptor). It wa… Continue reading

Synthego Receives Intel Capital Investment to Advance CRISPR Bioinformatics – Marketwired (press release)

Synthego Receives Intel Capital Investment to Advance CRISPR BioinformaticsMarketwired (press release)With the pace of CRISPR genome engineering research increasing rapidly alongside continued efforts to sequence genomes worldwide, advanced tools and p… Continue reading